Home Indirect reference intervals of plasma and serum thyrotropin (TSH) concentrations from intra-laboratory data bases from several German and Italian medical centres
Article
Licensed
Unlicensed Requires Authentication

Indirect reference intervals of plasma and serum thyrotropin (TSH) concentrations from intra-laboratory data bases from several German and Italian medical centres

  • Farhad Arzideh , Werner Wosniok and Rainer Haeckel EMAIL logo
Published/Copyright: February 23, 2011

Abstract

Background: The dogma of establishing intra-laboratory reference limits (RLs) and their periodic review cannot be fulfilled by most laboratories due to the expenses involved. Thus, most laboratories adopt external sources for their RLs, often neglecting the problems of transferability. This is particularly problematic for analytes with a large diversity of existing RLs, as for example thyrotropin (TSH). Several attempts were taken to derive RLs from the large data pools stored in modern laboratory information systems. These attempts were further developed to a more sophisticated indirect procedure. The new approach can be considered a combined concept because it pre-excludes some subjects by direct criteria a-posterior. In the current study, the applicability of the new concept for modern protein bindings assays was examined for estimating RLs of serum and plasma TSH with data sets from several German and Italian laboratories.

Methods: A smoothed kernel density function was estimated for the distribution of the total mixed data of the sample group (combined data of non-diseased and diseased subjects). It was assumed that the “central” part of the distribution of all data represents the non-diseased (“healthy”) population. The central part was defined by truncation points using an optimisation method, and was used to estimate a Gaussian distribution of the values of presumably non-diseased subjects after Box-Cox transformation of the empirical data. This distribution was now considered as the distribution of the non-diseased subgroup. The percentiles of this parametrical distribution were calculated to obtain RLs.

Results: RLs determined by the indirect combined decomposition technique led to similar RLs as found by several recent study reports using a direct method according to international recommendations. Furthermore, the RLs obtained from 13 laboratories in two different European regions re-flected the well-known differences of various analytical procedures. Stratification for gender and age was necessary in contrast to earlier reports. With increasing age, an increase of the upper RL and the reference range was observed. Hospitalisation also affected the RLs. Common RLs appeared acceptable only within the same analytical systems. Some laboratories used RLs which were not appropriate for the population served.

Conclusions: The proposed strategy of combining exclusion criteria with a resolution technique led to retrospective RLs from intra-laboratory data pools for TSH which were comparable with directly determined RLs. Differences between laboratories were due primarily to the well-known bias of the different analytical procedures and to the status of the population.


Corresponding author: Rainer Haeckel, Bremer Zentrum für Laboratoriumsmedizin, Klinikum Bremen Mitte, 28205 Bremen, Germany Phone: +49 421 273446, Fax: +49 421 1631608

Received: 2010-5-5
Accepted: 2010-11-18
Published Online: 2011-02-23
Published in Print: 2011-04-01

©2011 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Nuclear and radiation accidents: the next and further challenge for laboratory diagnostics
  3. Reviews
  4. Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases
  5. Miniaturization and globalization of clinical laboratory activities
  6. Inflammatory markers in childhood asthma
  7. Age-related macular degeneration: genetic and clinical findings
  8. Opinion Paper
  9. Economic evidence in decision-making process in laboratory medicine
  10. Point
  11. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art
  12. Counterpoint
  13. Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus?
  14. Genetics and Molecular Diagnostics
  15. Non-invasive prenatal diagnosis of trisomy 21 by reverse transcriptase multiplex ligation-dependent probe amplification
  16. General Clinical Chemistry and Laboratory Medicine
  17. Evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA1c
  18. Evaluation of two HbA1c point-of-care analyzers
  19. Indirect reference intervals of plasma and serum thyrotropin (TSH) concentrations from intra-laboratory data bases from several German and Italian medical centres
  20. Pseudohypocalcemia caused by perchlorate (Irenat®)
  21. Serum cholesterol measured by isotope dilution liquid chromatography tandem mass spectrometry
  22. Confirmation of congenital adrenal hyperplasia by adrenal steroid profiling of filter paper dried blood samples using ultra-performance liquid chromatography-tandem mass spectrometry
  23. Sensitivity and specificity of the high fluorescent lymphocyte count-gate on the Sysmex XE-5000 hematology analyzer for detection of peripheral plasma cells
  24. Clauss assay and fibrinogen protein estimated by capillary zone electrophoresis
  25. High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice
  26. Cancer Diagnostics
  27. Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients
  28. MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma
  29. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma
  30. Cardiovascular Diseases
  31. B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent’s Screening TO Prevent Heart Failure) study
  32. Elevated concentrations of Nɛ-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation
  33. Letters to the Editor
  34. More on preanalytical variables affecting platelet function testing using light transmittance aggregometry
  35. Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification
  36. Why do different EQA schemes have apparently different limits of acceptability?
  37. Prevalence of antithyroid antibodies and thyroid-stimulating hormone concentration in young people
  38. Evaluation of multiplex PCR using dual-priming oligonucleotide for the detection of vanA and vanB in vancomycin-resistant enterococci
  39. The IFCC Task Force for Young Scientists
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.114/html
Scroll to top button